FBIOFortress Biotech, Inc.
2.685USD-2.01%Mkt Cap: 89.36M USDP/E: 0.83Last update: 2026-05-26

Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule fo…

Indicators:|

Key Statistics

Company
Market Cap89.36M USD
Enterprise Value77.76M USD
Revenue (TTM)63.26M USD
Gross Profit42.34M USD
Net Income (TTM)6.82M USD
Revenue/Share2.267 USD
Last Price2.685 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees78
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)0.83
P/E (Forward)-1.58
PEG
EV/EBITDA-1.19
EV/Revenue1.23
P/S1.46
P/B1.75
EPS (TTM)3.23
EPS (Forward)-1.76
52W Range
1.69035% of range4.530
52W High4.530 USD
52W Low1.690 USD
Profitability
Gross Margin66.92%
Oper. Margin-29.78%
EBITDA Margin-103.63%
Profit Margin10.77%
ROE13.66%
ROA3.67%
Growth
Revenue Growth6.30%
Earnings Growth
Cash Flow & Leverage
Operating CF-65.78M USD
CapEx (TTM)
FCF Margin-74.75%
FCF Yield-52.92%
Net Debt-12.16M USD
Net Debt/EBITDA0.19
Balance Sheet
Debt/Equity1.49
Current Ratio2.49
Quick Ratio2.20
Book Value/Sh1.590 USD
Cash/Share2.465 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:15
Split DateOct 10, 2023
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)11.00 USD
Target Range5.000 USD17.00 USD
# Analysts2
Ownership
Shares Out.33.22M
Float22.38M
Insiders22.79%
Institutions18.16%
Short Interest
Short Ratio10.4d
Short % Float18.13%
Short % Out.14.00%
Shares Short4.65M
Short (prev mo.)4.36M
Technical
SMA 502.553 (+5.2%)
SMA 2002.947 (-8.9%)
Beta1.16
S&P 52W Chg28.31%
Avg Vol (30d)341.50K
Avg Vol (10d)464.95K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)